MIZUHASHI SATORU 水橋覚

… Alternative Names

水橋覚ミズハシサトル

Less

Researcher Number	60965549
Other IDs	https://orcid.org/0000-0002-1579-2798
Affiliation (Current)	2025: 熊本大学, 大学院生命科学研究部(医), 特定研究員
Affiliation (based on the past Project Information) *help	2023: 熊本大学, 大学院生命科学研究部(医), 特定研究員
Review Section/Research Field	Principal Investigator Basic Section 53050:Dermatology-related
Keywords	Principal Investigator 遺伝子発現抑制 / FOXM1 / NAP1L4 / メラノーマ / 新規短鎖核酸 / staple核酸

Development of novel short nucleic acid targeting NAP1L4 for the treatment of melanomaPrincipal Investigator
- Principal Investigator
  
  水橋覚
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Kumamoto University

All 2024 2023

All Journal Article

[Journal Article] Deciphering the role of adjuvant therapy in melanoma and its actual benefits2024
- Author(s)
  Fukushima Satoshi、Miyashita Azusa、Kimura Toshihiro、Kuriyama Haruka、Mizuhashi Satoru、Ichigozaki Yuki、Masuguchi Shinichi
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 51 Issue: 3 Pages: 335-342
- DOI
  10.1111/1346-8138.17093
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16285, KAKENHI-PROJECT-23K15271, KAKENHI-PROJECT-21K08351
[Journal Article] A case of melanoma complicated with uveitis induced by two types of BRAF/MEK inhibitors and nivolumab treatment2023
- Author(s)
  Obaru Chiaki、Kimura Toshihiro、Yamamura Manami、Kuriyama Haruka、Kashiwada‐Nakamura Kayo、Mizuhashi Satoru、Matsumura Tomoyo、Watanabe Takahiro、Inoue Toshihiro、Fukushima Satoshi
- Journal Title
  
  The Journal of Dermatology
  
  Volume: 51 Issue: 4
- DOI
  10.1111/1346-8138.17015
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K16285, KAKENHI-PROJECT-23K15271, KAKENHI-PROJECT-21K08351, KAKENHI-PROJECT-21K09703
[Journal Article] Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)2023
- Author(s)
  Namikawa Kenjiro、Ito Takamichi、Yoshikawa Shusuke、Yoshino Koji、Kiniwa Yukiko、Ohe Shuichi、Isei Taiki、Takenouchi Tatsuya、Kato Hiroshi、Mizuhashi Satoru、Fukushima Satoshi、Yamamoto Yosuke、Inozume Takashi、Fujisawa Yasuhiro、Yamasaki Osamu、Nakamura Yasuhiro、Asai Jun、Maekawa Takeo、Funakoshi Takeru、et al
- Journal Title
  
  Cancer Medicine
  
  Volume: 12 Issue: 17 Pages: 17967-17980
- DOI
  10.1002/cam4.6438
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15271, KAKENHI-PROJECT-22K08424, KAKENHI-PROJECT-23K07765, KAKENHI-PROJECT-21K08351

1. 木村俊寛

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

MIZUHASHI SATORU 水橋覚

水橋覚ミズハシサトル

Research Projects

Research Products

Co-Researchers

Development of novel short nucleic acid targeting NAP1L4 for the treatment of melanomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Deciphering the role of adjuvant therapy in melanoma and its actual benefits2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A case of melanoma complicated with uveitis induced by two types of BRAF/MEK inhibitors and nivolumab treatment2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)2023

Author(s)

Journal Title

DOI

Data Source

MIZUHASHI SATORU 水橋 覚

水橋 覚 ミズハシ サトル

Research Projects

Research Products

Co-Researchers

Development of novel short nucleic acid targeting NAP1L4 for the treatment of melanomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Deciphering the role of adjuvant therapy in melanoma and its actual benefits2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A case of melanoma complicated with uveitis induced by two types of BRAF/MEK inhibitors and nivolumab treatment2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)2023

Author(s)

Journal Title

DOI

Data Source

MIZUHASHI SATORU 水橋覚

水橋覚ミズハシサトル